About
Dr. Nabakumar Pramanik received his PhD from the Indian Institute of Technology (IIT) Kharagpur, India, in Chemistry in 2009. After that, he worked as Research Associate (RA) at the Materials Science Centre, IIT Kharagpur for the duration of 2009 to 2010. Afterward, he served as a Postdoctoral Research Associate (PDF) at the National Taiwan University of Science and Technology (NTUST), Taipei, Taiwan, for the duration of 2010 to 2011. He has published many scientific papers in various international journals of repute. His research work has also been presented at various national and international conferences. For his research, he has been awarded the best prize at the International Conference on Materials Chemistry, Bhaba Atomic Research Centre (BARC), Mumbai, India in 2008. He also received the Best Teacher Award from the National Institute of Technology (NIT), Arunachal Pradesh, India in 2013 for his excellent teaching and research activities and he is the receiver of different prestigious Academic Accreditations, Recognitions, Fellowship, Awards, etc. from various organizations/professional bodies. He has been elected as a Fellow of the Indian Chemical Society (FICS), India in the year 2019. He achieved IOP Publishing Outstanding Reviewer Award in 2021 in recognition of the high quality and timeliness reviews of Journal papers. He has been honored as a potential and active Reviewer for the AICTE-prescribed Textbook entitled ‘Chemistry-I with Lab manual’, Khanna Book Publishing, New Delhi, India. Dr. Pramanik has also scored a rational and good rank out of scientists in India, Asia, and the world, in addition to that, the best scientist in Chemical Sciences and Natural Sciences in the AD Scientific Index (Rankings for Scientists), Rankings for World Scientists and University Rankings. He has been accredited for one of his published journal articles (paper) which has ranked in the 62nd percentile among the articles of a similar age published in all the journals and the 99th percentile (ranked 1st) of the articles of a similar age published in the journal ‘Polymer Bulletin’, Springer Nature Publication, 28 June 2023. He is a life member of the Society for Materials Chemistry (SMC), India, Indian Science Congress Association, India, Materials Research Society of India (MRSI), India, and the Indian Chemical Society, India. His main research interests include Organic-Inorganic hybrid materials, Materials Chemistry/Materials Science, Biopolymers, Biomaterials like Calcium phosphate-based materials, Hydroxyapatite, Nanomaterials, Nanostructures, and Ceramic-polymer nanocomposites, etc. Presently he is serving as an Associate Professor in the discipline of Chemistry under the Department of Basic and Applied Science, NIT, Arunachal Pradesh, India.
Employment
-
National Institute of Technology Arunachal Pradesh Associate Professor2022 - Present
-
National Institute of Technology Arunachal Pradesh Assistant Professor2011 - 2022
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (113)
- Advancements in Iron Oxide Nanocomposites: Synthesis, Characterization, and Their Role in Bioimaging and Multifunctional Biomedical Applications Save
- Biofunctional Applications of Chitin, Chitosan, and Their Derivatives Save
- Green synthesis to biomedical applications: zinc oxide nanoparticles in eco-friendly formulations Save
- Antifungal Activity of a Fluconazole‐Conjugated ZnO─TiO2─Chitosan Biopolymer Composite Save
- Synthesis of Chitosan Biopolymer Nanocomposites Save
- Triazole-Linked Pyrene Sugar Analogue for Recognition of Picric Acid in Aqueous Medium Save
- Iron Oxide Nanoparticles for Engineering Applications: Synthesis, Properties and Performance Save
- Bioimaging Applications of Metal and Metal Oxide Nanoparticles Save
- Doxorubicin (DOX) modified zinc oxide (ZnO) nanocomposite encapsulated with polymethyl methacrylate (PMMA) biopolymer for effective cancer treatment Save
- Fluconazole Functionalized Copper Oxide—Chitosan Nanocomposite for Bioengineering Applications Against Human Breast Cancer Therapies Save